Yoshimura, Kanagawa
Chiaki Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20090104167 | Prophylactic/Ameliorating Agent for Menopausal Disorder and Functional Beverage/Food - Disclosed is a method for producing an estrogen-like active intermediate (e.g., secoisolariciresinol) by culturing a lignan (e.g., a lignan derived from | 04-23-2009 |
Hideaki Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20140294009 | COMMUNICATION APPARATUS, COMMUNICATION SYSTEM, CONTROL METHOD OF COMMUNICATION APPARATUS AND PROGRAM - There is provided a communication apparatus including a transmission source mapping algorithm acquisition unit configured to acquire an algorithm that assigns an external address and an external port number to an internal address and an internal port number of a transmission source, as a transmission source mapping algorithm, a destination mapping algorithm acquisition unit configured to acquire an algorithm that assigns an external address and an external port number to an internal address and an internal port number of a destination, as a destination mapping algorithm, and a generation unit configured to generate an external port number newly assigned to the internal address and the internal port number of the destination in a case where the transmission source mapping algorithm is more complicated than the destination mapping algorithm. | 10-02-2014 |
Hidetoshi Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20110293945 | VINYLIDENE FLUORIDE RESIN FILM - Provided is a vinylidene fluoride resin film that has good adhesiveness to a base material, achieves good dispersivity even when a pigment is contained in large amounts, and has excellent thermal stability during a forming process. | 12-01-2011 |
Hisashi Yoshimura, Kanagawa JP
Koichi Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20100319879 | MULTI-PRESSURE CONDENSER AND CONDENSATE REHEATING METHOD - A multi-pressure condenser has first and second condensers with vacuum pressures. The second condenser has a higher pressure. The first condenser has a first cooling water tube bundle, and a pressure barrier which extends below the first cooling water tube bundle. A heat-transfer tube introduces fluid from outside the first condenser into the first hot well below the barrier. Liquid is dropped into the first hot well through the through holes of the pressure barrier. The second condenser has a second cooling water tube bundle. Condensate generated in the high-pressure chamber is accumulated below the second cooling water tube bundle. The multi-pressure condenser further has a steam duct to connect the gas phase parts of the first hot well and the second condenser, and a pipe to communicate the liquid phase parts of the first hot well and the second condenser. | 12-23-2010 |
20140060052 | MOISTURE SEPARATOR REHEATER AND NUCLEAR POWER PLANT - One embodiment of a moisture separator reheater includes: heater headers that supply the heating fluid to heat transfer tube groups for heat exchange with the steam; partition plates that guide the steam from a moisture removal section to the heat transfer tube group and then to the heat transfer tube group. The heat transfer tube groups each includes a plurality of heat transfer tubes each having a forward passage part, a backward passage part, and a bent tube part. The forward and the backward passage parts extend in a longitudinal direction of a body drum and the bent tube part connects the forward and the backward passage parts. The bent tube pipe is provided outside end plates. | 03-06-2014 |
Koji Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20100318790 | CARD MANAGEMENT DEVICE AND CARD MANAGEMENT SYSTEM - A card management device includes: a card device configured to include a controller on which a cryptographic IP is mounted in advance; and an individual information writing device configured to allow the card device to be connected to the individual information writing device in such a way that the card device is capable of data transfer to the individual information writing device, individual information assigned to the card device in advance being set in the individual information writing device, the individual information writing device being capable of writing the individual information to the card device connected to the individual information writing device. | 12-16-2010 |
20110320810 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM - An information processing device includes: a data processing unit that executes a process of reproducing content recorded in a medium; and a memory storing a content revocation list in which an identifier (ID) of revoked content is recorded, wherein the data processing unit compares a minimum allowable version of a content revocation list recorded in a token which is management data corresponding to content recorded in the medium with a version of a content revocation list acquired from the memory, and when the version of the content revocation list acquired from the memory is an old version lower than the minimum allowable version of the content revocation list recorded in the token, the data processing unit halts determination on revocation of content based on the content revocation list acquired from the memory and reproduction of content. | 12-29-2011 |
20110320811 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM - An information processing device includes: a data processing unit that executes a process of reproducing content recorded in a medium, wherein the data processing unit acquires a token from the medium, the token being management data corresponding to content recorded in the medium, compares a server ID recorded in the acquired token with a server ID recorded in a server certificate acquired from a server from which the management data is acquired, and halts reproduction of content when the two server IDs are not identical. | 12-29-2011 |
20110320812 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM - An information processing device includes: a memory having a protected area which is a data recording area in which access restriction is set; and a data processing unit that determines accessibility in response to a request for accessing the protected area from an access requesting device, wherein the data processing unit verifies a device certificate received from the access requesting device and determines accessibility to the protected area based on access control information recorded in the device certificate. | 12-29-2011 |
20120036350 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND PROGRAM - An information processing apparatus includes a data processing unit which generates content to be distributed to a client; and a communication unit which sends the content generated by the data processing unit, wherein the data processing unit combines a plurality of watermarking record blocks, each of which is obtained by embedding watermarking data into a block as section data of the content, generates content in which different watermarking data sequences are set in units of distribution processing with respect to the clients, and sends the generated content to the clients through the communication unit. | 02-09-2012 |
20120045062 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM - An information processing device including: a data processing unit that generates an encryption key of content; and a communication unit that transmits an encryption key generated by the data processing unit, wherein the data processing unit generates, as the encryption key, individual keys that are different for each new content recording processing on a recording medium in a content recording device, and transmits the individual keys through the communication unit. | 02-23-2012 |
20120047360 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM - An information processing device including: a data processing unit that generates content for transmitting to a client; and a communication unit that transmits the generated content of the data processing unit, wherein the data processing unit generates, based on basic encrypted content having a plurality of units that each includes a SEED that is data for encryption key generation and a block that is encrypted data that is encrypted by an encryption key generated using the SEED, each data of (a) converted encrypted content on which conversion processing to replace the SEED with dummy data or to delete the SEED is performed, and (b) encrypted SEED that is the SEED encrypted by content transmission processing or by individual keys that are different by units of users at a transmission destination, and transmits the generated converted encrypted content and encrypted SEED as data provided to the client via the communication unit. | 02-23-2012 |
20120089843 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND PROGRAM - An information processing apparatus includes: a data processor which creates content to be distributed to a client, wherein the data processor executes processing of creating content provided to a client by selecting data in units of segments, which are division data of content, from a plurality of additional information recorded content items obtained by recording different additional information items on original content, selects different segment columns in units of content distribution clients in the processing of creating content provided to a client, and creates management information in which client information for identifying a client of a content distribution destination and segment column information indicating a segment selection state of the content provided to a client, which is provided to a corresponding client, are matched with each other and records the management information in a storage unit. | 04-12-2012 |
20120173799 | DATA STORAGE APPARATUS, INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND PROGRAM - An information storage apparatus that includes a memory unit, a first controller that reads data from the memory unit, and a second controller included in the memory unit that reads a first identification and outputs the first identification in response to an external instruction, wherein the first identification may only be read by the second controller. | 07-05-2012 |
20140122887 | INFORMATION PROCESSING APPARATUS, INFORMATION STORAGE APPARATUS, INFORMATION PROCESSING SYSTEM, AND INFORMATION PROCESSING METHOD AND PROGRAM - There is provided an information processing apparatus including: a data processing unit, on which a medium as an information storage apparatus is mounted, which controls reproduction of content stored on the medium, wherein the data processing unit executes host device ID registration processing for outputting a host device ID, which is an identifier of the host device, to the medium and storing the host device ID on the medium, receives the host device ID, which is stored on the medium, from the medium after execution of the host device ID registration processing, executes connection consistency confirmation processing for executing matching processing between the received host ID and the host device ID of the host device, and executes or continues content reproduction under a condition that the matching processing has been established in the connection consistency confirmation processing, or stops the content reproduction if the matching processing has not been established. | 05-01-2014 |
20140351585 | INFORMATION STORAGE DEVICE, INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM - There is provided a device and a method for preventing using of illegitimate content or manufacturing of the illegitimate media that uses illegitimate media. In a system that has an information storage device, a license management apparatus that generates a media key set (MKS) that is stored in the information storage device, and a content provision apparatus, at the time of manufacturing of the information storage device, the license management apparatus compares an MKS version that is set in the MKS that is stored in the information storage device, and an allowance minimum MKS version that is recorded in a controller of the information storage device, and thus records key information stored in the MKS, in a storage unit under the condition that it is confirmed that the MKS version is equal to or greater in value than the allowance minimum MKS version. | 11-27-2014 |
20150046719 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM - An information processing device including: a data processing unit that generates an encryption key of content; and a communication unit that transmits an encryption key generated by the data processing unit, wherein the data processing unit generates, as the encryption key, individual keys that are different for each new content recording prates sing on a recording medium in a content recording device, and transmits the individual keys through the communication unit. | 02-12-2015 |
20150143131 | INFORMATION PROCESSING DEVICE, INFORMATION STORAGE DEVICE, INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM - According to a first aspect of the present disclosure, there is provided an information storage device including a storage unit that stores encrypted content, usage control information of the encrypted content, and a revocation list in which revocation information of a content reproduction device is recorded, and a data processing unit that determines whether content reproduction of an information processing device which performs decoding of the encrypted content is permitted. The data processing unit acquires an entry identifier which is designation information for a registration entry of the revocation list recorded in the usage control information, executes an identifier registration determination process for determining whether an identifier of the information processing device which performs decoding of the encrypted content is registered in the entry of the revocation list identified according to the acquired entry identifier, and determines whether a subkey which is a generation key for a title key applied to the decoding of the encrypted content is to be provided to the information processing device based on a result of the identifier registration determination process. | 05-21-2015 |
Kosaku Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20140255839 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, AND TONER CARTRIDGE - An electrostatic charge image developing toner includes a binder resin and a release agent, and when a peak temperature during a first temperature increase and a peak temperature during a second temperature increase, that are obtained by differential scanning calorimetry including performing the first temperature increase at 10° C./min after holding at 10° C., performing cooling at −10° C./min, performing a heat treatment for 24 hours at 50° C., and performing the second temperature increase at 10° C./min, are represented by Tt1 and Tt2 | 09-11-2014 |
20150044601 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, AND TONER CARTRIDGE - An electrostatic charge image developing toner includes toner particles containing a binder resin containing a polyester resin forming a sea part and a vinyl resin forming an island part of a sea-island structure, a first release agent existing in the sea part in a domain state, and a second release agent existing in the island part in a domain state, wherein when a cross-sectional area of the second release agent is set to A1 and a cross-sectional area of the first release agent is set to B1 in a cross section of the toner particles, a relationship of 0.2≦A1/B1≦0.8 is satisfied. | 02-12-2015 |
20160091811 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS - An electrostatic charge image developing toner includes a binder resin containing an amorphous polyester resin and a crystalline polyester resin, wherein a ratio of the crystalline polyester resin to a total of the amorphous polyester resin and the crystalline polyester resin is from 12% to 40% by weight, and the toner satisfies the following equations (1) and (2), | 03-31-2016 |
Kousaku Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20110076466 | TONER COMPOSITION FOR ELECTROSTATIC PHOTOGRAPHY, DEVELOPER FOR ELECTROSTATIC PHOTOGRAPHY, METHOD OF FORMING ELECTROSTATIC PHOTOGRAPHIC IMAGE, AND ELECTROSTATIC PHOTOGRAPHIC IMAGE - The present invention provides a toner composition for electrostatic photography, including a reactive compound A having a reactive group XA, and a reactive compound B having a reactive group XB that is capable of reacting with the reactive group XA and forming a bond, wherein the reactive compound B is capable of forming a three-dimensionally bonded structure by reacting with the reactive compound A, and wherein the toner composition includes the reactive compound A and the reactive compound B in a mutually isolated state. | 03-31-2011 |
20130017481 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHODAANM MAEHATA; HideoAACI KanagawaAACO JPAAGP MAEHATA; Hideo Kanagawa JPAANM MERA; FumiakiAACI KanagawaAACO JPAAGP MERA; Fumiaki Kanagawa JPAANM YOSHIMURA; KousakuAACI KanagawaAACO JPAAGP YOSHIMURA; Kousaku Kanagawa JP - An electrostatic charge image developing toner includes: a polyester resin containing a graft copolymer, the graft copolymer being formed with a polyester skeleton as a main chain and block copolymers containing a styrene-based polymer block and a crystalline acrylate-based polymer block. The styrene-based polymer block is grafted onto the polyester skeleton. | 01-17-2013 |
Masaki Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20100054341 | Audio visual system and decoder therefor - An audio visual system includes an input unit for receiving data containing video data and audio data and dividing the data into the audio data and the video data, a video decoder for decoding the video data divided by the input unit, an audio decoder for decoding the audio data divided by the input unit, and an output unit for superimposing and outputting the video data decoded by the video decoder and the audio data decoded by the audio decoder. The video decoder or audio decoder has a plurality of data output paths and sets delay times for each of the output paths to synchronize the decoded video data with the decoded audio data. | 03-04-2010 |
20130151544 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND PROGAM - An apparatus for processing content data may include a memory. The apparatus may also include a buffer controller, which may be configured to overwrite recorded content data stored in the memory with new content data. The buffer controller may also be configured to receive a command signal indicative of a search request. Additionally, the buffer controller may be configured to, in response to the command signal, stop the overwriting. In addition, the apparatus may include a result display unit, which may be configured to generate a display signal to cause display of information regarding content represented by at least a portion of the recorded content data. | 06-13-2013 |
Masanori Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20090069443 | Sedative Effect-Imparting Agent And Sedative Perfume Composition Containing The Same - It is intended to provide a sedative effect-imparting agent that provides excellent sedative effect with good fragrance-releasing property, and is possible to provide the excellent sedative effect immediately. | 03-12-2009 |
20110236447 | Oil-In-Water Cosmetics - The present invention provides an oil-in-water cosmetic excellent in emulsion stability. The oil-in-water cosmetic includes (a) oil-droplet particles consisting of an oil component to be emulsified; (b) vesicle particles for stabilizing the oil-droplet particles; and (c) an aqueous phase containing water and a monohydric aliphatic alcohol having 1 to 4 carbon atoms. It is preferred that the vesicle particles are formed with an amphiphilic substance which spontaneously forms vesicle particles, and that they are localized on surfaces of the oil-droplet particles. It is preferred that the amphiphilic substance be a polyoxyethylene hydrogenated castor oil derivative represented by the following formula (1), wherein E=L+M+N+X+Y+Z, and that said E which represents the average addition mole number of ethylene oxide is 10 to 20. | 09-29-2011 |
Osamu Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20080285514 | Wireless Communication Apparatus, Method and Program Storage Medium - A wireless communication apparatus having a wireless communication function capable of using a plurality of transmission rates. The wireless communication apparatus includes utilization-factor calculation means for calculating a utilization factor of a wireless transmission path through which wireless communication is performed using the wireless communication function; and determination means for determining a transmission rate at least on the basis of the utilization factor calculated by the utilization-factor calculation means. | 11-20-2008 |
20080287069 | Wireless Communication Apparatus, Program, Wireless Communication Method and Wireless Communication System - A wireless communication apparatus includes a transmitting portion to transmit a data signal to other wireless communication apparatus, a receiving portion to receive a reception confirmation signal indicating reception of the data signal by the other wireless communication apparatus from the other wireless communication apparatus during a specified period, a determination portion to determine that a predetermined requirement is satisfied if the receiving portion receives a given signal during the specified period, and a control portion to control the transmitting portion to request the other wireless communication apparatus to retransmit the reception confirmation signal if the receiving portion does not normally receive the reception confirmation signal and the determination portion determines that the predetermined requirement is satisfied. | 11-20-2008 |
20100040007 | Wireless Communication Device, Communication System, and Communication Control Method, and Program - A wireless communication device includes a control unit for performing a processing on communication data and a memory storing the communication data, in which the control unit performs a processing on data received via a direct link path and a path via a relay point, stores the data received via the respective paths in plural reorder buffers corresponding to the communication paths set in the memory, after a communication path switch decision processing, stores data from a new channel in a new channel reorder buffer and prohibits transfer to a higher-level layer, and when data indicating a trailing end frame is received from an existing channel, or a stand-by time elapses, or the data stored in the reorder buffer for the new channel reaches a specified threshold, performs a transfer processing for the data stored in the reorder buffer for the new channel to the higher-level layer. | 02-18-2010 |
20100254361 | WIRELESS COMMUNICATION DEVICE, WIRELESS COMMUNICATION SYSTEM, WIRELESS COMMUNICATION METHOD AND PROGRAM - Provided is a wireless communication device which includes a function information transmitting unit for transmitting, via a wireless communication network, function information relating to a function of the wireless communication device, a function information receiving unit for receiving function information transmitted from another device, a function information comparison unit for comparing the function information of the wireless communication device and the function information received from such other device, and a function determination unit for determining which of the wireless communication device and such other device is to play a function of an access point, based on a result of the comparison by the function information comparison unit. | 10-07-2010 |
20110249181 | TRANSMITTING DEVICE, RECEIVING DEVICE, CONTROL METHOD, AND COMMUNICATION SYSTEM - Disclosed herein is a transmitting device, including: a reproduction time information adding portion configured to add reproduction time information specifying timing of reproduction of data as an object of transmission to the data; a control time information adding portion configured to add control time information specifying control timing when circuit control is performed on a circuit, the data being to be transmitted through the circuit, to data transfer control information; and a transmitting portion configured to transmit data to which the reproduction time information and the control time information are added. | 10-13-2011 |
20110305281 | RECEIVER, RECEIVING METHOD, AND COMMUNICATION SYSTEM - A receiver includes a receiving section that receives communication packets transmitted from a transmitter, which transmits the communication packets each including encoded data, and an image header, sequentially from the encoded data corresponding to the beginning of an image, a first accumulating section that accumulates the encoded data and the image header included in each of the received communication packets, a detecting section that detects a picture header transmitted together with the encoded data corresponding to the beginning of the image, from the image header of each of the received communication packets, in a predetermined observation interval, a second accumulating section that accumulates the detected picture header, and a control section that reads out the picture header accumulated in the second accumulating section, and causes the picture header to be accumulated into the first accumulating section, if the picture header is not detected within the observation interval. | 12-15-2011 |
20120039194 | INFORMATION PROCESSING DEVICE AND METHOD, AND PROGRAM - There is provided an information processing device including an adjustment unit that adjusts respective lengths of delay times, which delay data transmission, for a plurality of different delay elements regarding the data transmission, so as to match with the longest delay time of the plurality of delay times or a predetermined time equal to or more than the longest delay time, and a setting unit that sets the respective plurality of delay times of which the lengths are adjusted by the adjustment unit in a processing unit which performs a process for the data transmission. | 02-16-2012 |
20120250547 | WIRELESS COMMUNICATION DEVICE, WIRELESS COMMUNICATION METHOD, AND WIRELESS COMMUNICATION SYSTEM - A wireless communication device includes: a data transmission unit that transmits data to one or more receiving terminals; and a communication mode determination unit that determines a communication mode in which the data is transmitted from the data transmission unit, wherein the communication mode determination unit selects a first communication mode in which unicast communication is used when the number of receiving terminals to which the data is transmitted is equal to or less than a predetermined number, and selects a second communication mode in which unicast communication is performed to one or some of receiving terminals as a destination and the other receiving terminals than the destination also receive packets in unicast communication when the number of receiving terminals to which the data is transmitted exceeds the predetermined number. | 10-04-2012 |
20120254354 | COMMUNICATION DEVICE, RECEIVING DEVICE, COMMUNICATION METHOD, AND COMMUNICATION SYSTEM - There is provided a communication device including a communication unit configured to receive communication data transmitted/received between a transmitting device and a receiving device that is a transmission target of transmission data transmitted by the transmitting device by unicast, a data determination unit configured to determine data to be used for a process from among the received communication data, and a processing unit configured to process the data determined to be used for the process. The processing unit, in processing the determined data, prevents the communication unit from responding to the transmitting device or the receiving device. | 10-04-2012 |
20120256965 | DISPLAY CONTROL DEVICE, DISPLAY CONTROL METHOD, PROGRAM, AND DISPLAY CONTROL SYSTEM - There is provided a display control device, including a communication section for communicating with an external device, a position specification section for specifying positions of an imaging device, which captures an image, and a display device, which displays the image, a process determination section for determining whether to cause the captured image to be reversed in a horizontal direction on the basis of the positions of the display device and the imaging device and a processing section for selectively reversing the captured image in the horizontal direction, wherein the processing section causes the display device to display the image reversed in the horizontal direction by reversing the captured image in the horizontal direction, if the image is determined to be reversed in the horizontal direction, and causes the display device to display the captured image, if the image is determined not to be reversed in the horizontal direction. | 10-11-2012 |
20120300612 | COMMUNICATION APPARATUS, COMMUNICATION METHOD, AND COMMUNICATION SYSTEM - There is provided a communication apparatus including a communication unit that receives first communication data transmitted from a transmitting apparatus to a first receiving apparatus through unicast and second communication data transmitted from the transmitting apparatus to a second receiving apparatus, respectively and a processing unit that processes processing data included in the received first communication data and second communication data. When there is missing data in either of first processing data included in the first communication data and second processing data included in the second communication data, the processing unit executes processing using the other processing data in which there is no missing data, and the processing unit does not make the communication unit transmit a reply with respect to external apparatuses. | 11-29-2012 |
20130136218 | INFORMATION PROCESSING APPARATUS, METHOD, AND PROGRAM - The present invention relates to an information processing apparatus, a method, and a program capable of suppressing deterioration of content quality. An integrated reception buffer time adjustment unit 114 obtains a maximum transmission delay time that is the longest delay time among the transmission delays of data transmission performed by each reception unit 113. The reception buffer time setting unit 208 calculates a reception buffer time using the maximum transmission delay time, a transmission delay time of the data transmission by the reception unit 113, and a prescribed reception buffer time. The reception buffer time setting unit 208 sets various delay times and waiting times such as a variable compression encoding delay time, a redundant encoding block reception waiting time, an ARQ retransmission packet waiting time, and a network jitter handling buffer time from the reception buffer time. The present invention can be applied to an information processing apparatus, for example. | 05-30-2013 |
20150067452 | INFORMATION PROCESSING APPARATUS AND METHOD, AND, PROGRAM - The present technique relates to an information processing apparatus and a method, and a program, capable of reducing a delay time. An information processing apparatus according to the present technique is an information processing apparatus including an estimation unit configured to estimate, on the basis of a transmission buffer waiting time which is a time it takes to accumulate encoded data obtained by encoding image data when encoding the image data which are to be transmitted, a reception buffer waiting time which is a time it takes to accumulate the encoded data before the encoded data are decoded at a transmission destination of the encoded data, and a setting unit configured to set a block length which is a processing unit of error correction processing in such a manner that an error correction reception delay time which is a delay time in the error correction processing performed at the transmission destination of the encoded data does not become more than the reception buffer waiting time estimated by the estimation unit. The present technique can be applied to, for example, an information processing apparatus. | 03-05-2015 |
20150117434 | WIRELESS COMMUNICATION DEVICE, WIRELESS COMMUNICATION SYSTEM, WIRELESS COMMUNICATION METHOD AND PROGRAM - Provided is a wireless communication device which includes a function information transmitting unit for transmitting, via a wireless communication network, function information relating to a function of the wireless communication device, a function information receiving unit for receiving function information transmitted from another device, a function information comparison unit for comparing the function information of the wireless communication device and the function information received from such other device, and a function determination unit for determining which of the wireless communication device and such other device is to play a function of an access point, based on a result of the comparison by the function information comparison unit. | 04-30-2015 |
20160080825 | INFORMATION PROCESSING APPARATUS AND INFORMATION PROCESSING METHOD - To perform an appropriate data transmission rate control. | 03-17-2016 |
Reiko Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20100072420 | METHOD OF PRODUCING A METALLIC NANOPARTICLE INORGANIC COMPOSITE, METALLIC NANOPARTICLE INORGANIC COMPOSITE, AND PLASMON WAVEGUIDE - A method using a chemical synthesis method to produce a metallic nanoparticle inorganic composite having fine metallic nanoparticles that are uniformly dispersed at a high density in a solidified matrix, a metallic nanoparticle inorganic composite, and a plasmon waveguide using this composite are provided. Thus, a method including: preparing a precursor solution, applying the precursor solution onto a substrate, and then hydrolyzing the precursor solution to form an oxide film having fine pores, bringing the oxide film into contact with an acidic aqueous solution of tin chloride to chemically adsorb Sn | 03-25-2010 |
20120241713 | ORGANIC MOLECULAR MEMORY - An organic molecular memory of an embodiment includes a first conductive layer, a second conductive layer, and an organic molecular layer interposed between the first conductive layer and the second conductive layer, the organic molecular layer including charge-storage molecular chains or variable-resistance molecular chains, the charge-storage molecular chains or the variable-resistance molecular chains including fused polycyclic groups. | 09-27-2012 |
20150228335 | ORGANIC MOLECULAR MEMORY - An organic molecular memory of an embodiment includes a first conductive layer, a second conductive layer, and an organic molecular layer interposed between the first conductive layer and the second conductive layer, the organic molecular layer including charge-storage molecular chains or variable-resistance molecular chains, the charge-storage molecular chains or the variable-resistance molecular chains including fused polycyclic groups. | 08-13-2015 |
Ryoko Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20080252901 | Wavelength-Tunable Light Source And Optical Coherence Tomography - The present invention provides an OCT technique that permits tomographic observation of a biological body parts that is difficult to restrain and also provides a tomographic observation technique for the observation of a constrainable part that does not require constraint and remove the burden from biological body. A wavelength-tunable light generator (wavelength-tunable light source) is employed as the light source of the optical coherence tomography device. The wavelength-tunable light generator has a wave number tunable range width of at least 4.7×10 | 10-16-2008 |
20090002713 | Optical Coherence Tomography System - There is provided an optical coherent tomography device capable of enlarging a measurement range by removing the affect of a folded image. The device includes an optical phase modulator ( | 01-01-2009 |
20090273790 | WAVELENGTH-TUNABLE LIGHT GENERATOR AND OPTICAL COHERENCE TOMOGRAPHY DEVICE - The present invention provides an OCT technique that permits tomographic observation of a biological body parts that is difficult to restrain and also provides a tomographic observation technique for the observation of a constrainable part that does not require constraint and remove the burden from biological body. A wavelength-tunable light generator (wavelength-tunable light source) is employed as the light source of the optical coherence tomography device. The wavelength-tunable light generator has a wave number tunable range width of at least 4.7×10 | 11-05-2009 |
Sachiko Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20100040641 | PEPTIDE VACCINES FOR CANCERS EXPRESSING TUMOR-ASSOCIATED ANTIGENS - The present invention provides peptides having an amino acid sequence as set forth in SEQ ID NO: 19, 22, 30, 34, 344, 358, 41, 44, 46, 48, 78, 376, 379, 80, 100, 101, 110, 111, 387, 112, 394, 114, 116, 117, 121, 395, 133, 135, 137, 426, 143, 147, 148, 149, 150, 152, 153, 154, 156, 160, 161, 162, 163, 166, 174, 178, 186, 194, 196, 202, 210, 213, 214, 217, 223, 227, 228, 233, 254, 271, 272 or 288, as well as peptides having the above-mentioned amino acid sequences in which 1, 2, or several (e.g., up to 5) amino acids are substituted, deleted, or added, provided the peptides possess cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing a disease associated with over-expression of the CDH3, EPHA4, ECT2, HIG2, INHBB, KIF20A, KNTC2, TTK and/or URLC10, e.g. cancers containing as an active ingredient one or more of these peptides. The peptides of the present invention find further utility as vaccines. | 02-18-2010 |
20110189214 | CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. In particular, the present invention describes epitope peptides derived from CDCA1 that elicit CTLs. The present invention also provides established CTLs that specifically recognize HLA-A24 positive target cells pulsed with the peptides. Antigen-presenting cells and exosomes that present any of the peptides, as well as methods for inducing antigen-presenting cells are also provided. The present invention further provides pharmaceutical agents containing the CDCA1 polypeptides or polynucleotides encoding thereof, as well as exosomes and antigen-presenting cells as active ingredients. Furthermore, the present invention provides methods for treating and/or prophylaxis of (i.e., preventing) cancers (tumors), and/or prevention of postoperative recurrence thereof, as well as methods for inducing CTLs, methods for inducing anti-tumor immunity, using the CDCA1 polypeptides, polynucleotides encoding the polypeptides, exosomes or antigen-presenting cells presenting the polypeptides, or the pharmaceutical agents of the present invention. The cancers to be targeted include, but are not limited to, breast cancer, bladder cancer, esophageal cancer, small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). | 08-04-2011 |
20110200626 | IQGAP3 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. In particular, the present invention describes epitope peptides derived from IQGAP3 that elicit CTLs. The present invention also provides established CTLs that specifically recognize HLA-A24 or HLA-A02 positive target cells pulsed with the peptides. Antigen-presenting cells and exosomes that present any of the peptides, as well as methods for inducing antigen-presenting cells are also provided. The present invention further provides pharmaceutical agents containing the IQGAP3 polypeptides or polynucleotides encoding thereof, as well as exosomes and antigen-presenting cells as active ingredients. Furthermore, the present invention provides methods for treating and/or prophylaxis of (i.e., preventing) cancers (tumors), and/or prevention of postoperative recurrence thereof, as well as methods for inducing CTLs, methods for inducing anti-tumor immunity, using the IQGAP3 polypeptides, polynucleotides encoding the polypeptides, exosomes or antigen-presenting cells presenting the polypeptides, or the pharmaceutical agents of the present invention. The cancers to be targeted include, but are not limited to, renal, esophageal, gastric, lung, breast, bladder and pancreatic cancer. | 08-18-2011 |
20110243973 | HIG2 AND URLC10 EPITOPE PEPTIDE AND VACCINES CONTAINING THE SAME - The present invention provides a pharmaceutical agent or composition containing one or more peptides having the amino acid sequence of SEQ ID NO: 1 or 2, or one or more polynucleotides encoding such a peptide formulated for the treatment and/or prevention of cancer in a subject whose HLA-A antigen is HLA-A0206. Furthermore, the present invention provides a method of inducing CTL and antigen-presenting cells using such peptides, polynucleotides or pharmaceutical agents. | 10-06-2011 |
20110280898 | INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. In particular, the present invention describes epitope peptides derived from INHBB that elicit CTLs. The present invention also provides established CTLs that specifically recognize HLA-A02 positive target cells pulsed with the peptides. Antigen-presenting cells and exosomes that present any of the peptides, as well as methods for inducing antigen-presenting cells are also provided. The present invention further provides pharmaceutical compositions containing the INHBB polypeptides or polynucleotides encoding thereof, as well as exosomes and antigen-presenting cells as active ingredients. Furthermore, the present invention provides methods for the treatment and/or prophylaxis of cancers, and/or prevention of postoperative recurrence thereof, as well as methods for inducing CTLs, methods for inducing anti-tumor immunity, using the INHBB polypeptides, polynucleotides encoding the polypeptides, exosomes or antigen-presenting cells presenting the polypeptides, or the pharmaceutical agents of the present invention. | 11-17-2011 |
20110293645 | WDRPUH EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME - The present invention provides peptides containing the amino acid sequence of SEQ ID NOs: 1, 2, 3, 4, 16, 17, 30, 31, 34, 36, 37, 40, 41, 45, 49, 55, 57 and 61, as well as peptides containing the above-mentioned amino acid sequences in which 1, 2, or several amino acid(s) are substituted, deleted, inserted or added, but still have cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing tumors, which drugs containing these peptides. The peptides of the present invention can also be used as vaccines. | 12-01-2011 |
20120003253 | C1ORF59 PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated peptides having the amino acid sequence of SEQ ID NO: 43 or immunologically active fragments thereof, which bind to HLA antigen and have cytotoxic T lymphocyte (CTL) inducibility. The present invention further provides peptides which include one, two, or several amino acid insertions, substitution or addition to the aforementioned peptides or fragments, but still have the cytotoxic T cell inducibility. Further provided are nucleic acids encoding any of these aforementioned peptides as well as pharmaceutical agents and compositions including any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical agents and compositions of this invention may be used for treating cancer or tumor. | 01-05-2012 |
20120093845 | NEIL3 PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 45, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include the above mentioned amino acid sequence with substitution deletion, or addition of one, two, or several amino acids sequences. The invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for diagnosing or treating cancer. | 04-19-2012 |
20120107333 | VANGL1 PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 35, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for treating cancer. | 05-03-2012 |
20120128705 | C6ORF167 PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. In particular, epitope peptides derived from the C6orf167 gene that elicit CTLs are provided. Antigen-presenting cells and isolated CTLs that target such peptides, as well as methods for inducing the antigen-presenting cell, or CTL are also provided. The present invention further provides pharmaceutical compositions containing peptides derived from C6orf167 or polynucleotides encoding the polypeptides as active ingredients. Furthermore, the present invention provides methods for the treatment and/or prophylaxis of (i.e., preventing) cancers (tumors), and/or the prevention of postoperative recurrence thereof, as well as methods for inducing CTLs, methods for inducing anti-tumor immunity, using the peptides derived from C6orf167, polynucleotides encoding the peptides, or antigen-presenting cells presenting the peptides, or the pharmaceutical compositions of the present invention. | 05-24-2012 |
20120135020 | TTK PEPTIDES AND VACCINES INCLUDING THE SAME - Peptide vaccines against cancer are described herein. In particular, epitope peptides derived from the TTK gene that elicit CTLs are provided. Antigen-presenting cells and isolated CTLs that target such peptides, as well as methods for inducing the antigen-presenting cell, or CTL are also provided. The present invention further provides pharmaceutical compositions containing as active ingredients peptides derived from TTK or polynucleotides encoding the peptides. Furthermore, the present invention provides methods for the treatment and/or prophylaxis (i.e., prevention) of cancers (tumors), and/or the prevention of postoperative recurrence thereof, as well as methods for inducing CTLs, methods for inducing anti-tumor immunity, using the peptides derived from TTK, polynucleotides encoding the peptides, or antigen-presenting cells presenting the peptides, or the pharmaceutical compositions of the present invention. | 05-31-2012 |
20120156231 | FOXM1 PEPTIDES AND VACCINES CONTAINING THE SAME - The present invention provides isolated peptides having the amino acid sequence of SEQ ID NO: 34 or fragments thereof, which bind to HLA antigen and induce cytotoxic T lymphocyte (CTL). The present invention further provides peptides which include one, two, or several amino acid insertions, substitution or addition to the aforementioned peptides or fragments, but still have the cytotoxic T cell inducibility. Further provided are nucleic acids encoding any of these aforementioned peptides as well as pharmaceutical substances or compositions including any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical substances or compositions of the present invention may be used for treating cancer or tumor. | 06-21-2012 |
20120308591 | TMEM22 PEPTIDES AND VACCINES INCLUDING THE SAME - Isolated peptides composed of the amino acid sequence of SEQ ID NO: 33 or fragments thereof that bind to HLA antigens and have cytotoxic T lymphocyte (CTL) inducibility and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines are described herein. The present invention further provides peptides that include one, two, or several amino acid insertions, substitutions or additions to the aforementioned peptides or fragments, but yet retain the requisite cytotoxic T cell inducibility. Further provided are nucleic acids encoding any of these aforementioned peptides as well as pharmaceutical agents, substances and compositions including any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical agents, substances and compositions of this invention find particular utility in the treatment of cancers and tumors. | 12-06-2012 |
20120328638 | MYBL2 PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. In particular, epitope peptides derived from the MYBL2 gene that bind to HLA antigen and have cytotoxic T lymphocyte (CTL) inducibility, more particularly peptides having the amino acid sequence of SEQ ID NO: 5 and fragments thereof, are provided. The present invention further extends to peptides that include one, two, or several amino acid insertions, substitutions or additions to the aforementioned peptides or fragments, provided they retain cytotoxic T cell inducibility. Also provided as nucleic acids encoding any of the aforementioned peptides, antigen-presenting cells and isolated CTLs that target such peptides, and pharmaceutical agents and compositions including any of the aforementioned peptides, nucleic acids, and APCs as active ingredients. The components of the present invention have particular utility in connection with the treatment and/or prophylaxis (i.e., prevention) of cancers (tumors), and/or the prevention of a postoperative recurrence thereof. | 12-27-2012 |
20130034574 | MODIFIED MELK PEPTIDES AND VACCINES CONTAINING THE SAME - Isolated peptides composed of the amino acid sequence of the modified MELK epitope peptide or immunologically active fragments thereof that bind to HLA antigens and have higher cytotoxic T lymphocyte (CTL) inducibility than that of the wild type MELK epitope peptide and thus are suitable for use in the context of cancer immunotherapy or endometriosis immunotherapy, more particularly cancer or endometriosis vaccines are described herein. The present invention further provides peptides that include one, two, or several amino acid insertions, substitutions or additions to the aforementioned peptides or fragments, but yet retain the requisite cytotoxic T cell inducibility. Further provided are nucleic acids encoding any of these aforementioned peptides as well as pharmaceutical substances and compositions including any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical substances and compositions of this invention find particular utility in the treatment of cancers, tumors, and endometriosis. | 02-07-2013 |
20130064840 | HJURP PEPTIDES AND VACCINES INCLUDING THE SAME - Isolated peptides derived from SEQ ID NO: 50 and fragments thereof that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines are described herein. The inventive peptides encompasses both the above mentioned amino acid sequences and modified versions thereof, in which one, two, or several amino acids sequences substituted, deleted, added or inserted, provided such modified versions retain the requisite cytotoxic T cell inducibility of the original sequence. Further provided are nucleic acids encoding any of the aforementioned peptides as well as pharmaceutical agents, substances and/or compositions that include or incorporate any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical agents, substances and compositions of this invention find particular utility in the treatment of cancers and tumors, including, for example, AML, bladder cancer, breast cancer, cervical cancer, cholangiocellular carcinoma, CML, colorectal cancer, esophagus cancer, Diffused-type gastric cancer, liver cancer, NSCLC, lymphoma, osteosarcoma, ovarian cancer, pancreatic cancer, prostate cancer, renal carcinoma, SCLC, soft tissue tumor and testicular tumor. | 03-14-2013 |
20130095128 | ECT2 PEPTIDES AND VACCINES INCLUDING THE SAME - Isolated peptides derived from SEQ ID NO: 42 and fragments thereof that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines, are described herein. The inventive peptides encompass both the afore-mentioned amino acid sequences and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted or added, provided such modified versions retain the requisite HLA binding and/or CTL inducibility of the original sequences. Further provided are nucleic acids encoding any of the aforementioned peptides as well as pharmaceutical agents, substances and/or compositions that include or incorporate any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical agents, substances and compositions of this invention find particular utility in the treatment of cancers and tumors, including, for example, bladder cancer, breast cancer, cervical cancer, cholangiocellular carcinoma, CML, colorectal cancer, esophageal cancer, NSCLC, lymphoma, pancreatic cancer, prostate cancer, renal carcinoma and SCLC. | 04-18-2013 |
20130108664 | CDCA5 PEPTIDES AND VACCINES INCLUDING THE SAME | 05-02-2013 |
20130189291 | Peptide Vaccines For Cancers Expressing Tumor-Associated Antigens - The present invention provides peptides having an amino acid sequence as set forth in SEQ ID NO: 19, 22, 30, 34, 344, 358, 41, 44, 46, 48, 78, 376, 379, 80, 100, 101, 110, 111, 387, 112, 394, 114, 116, 117, 121, 395, 133, 135, 137, 426, 143, 147, 148, 149, 150, 152, 153, 154, 156, 160, 161, 162, 163, 166, 174, 178, 186, 194, 196, 202, 210, 213, 214, 217, 223, 227, 228, 233, 254, 271, 272 or 288, as well as peptides having the above-mentioned amino acid sequences in which 1, 2, or several (e.g., up to 5) amino acids are substituted, deleted, or added, provided the peptides possess cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing a disease associated with over-expression of the CDH3, EPHA4, ECT2, HIG2, INHBB, KIF20A, KNTC2, TTK and/or URLC10, e.g. cancers containing as an active ingredient one or more of these peptides. The peptides of the present invention find further utility as vaccines. | 07-25-2013 |
20130287805 | C18ORF54 PEPTIDES AND VACCINES INCLUDING THE SAME - Peptide vaccines against cancer are described herein. In particular, isolated epitope peptides or immunogenic fragments derived from SEQ ID NO: 35, that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) are provided. The amino acid sequences of the peptide of interest may be optionally modified with the substitution, deletion, insertion, or addition of one, two, or several amino acids sequences. Pharmaceutical compositions and methods of treating cancer that include such peptides are also provided. | 10-31-2013 |
20130309259 | WDHD1 PEPTIDES AND VACCINES INCLUDING THE SAME - Peptide vaccines against cancer are described herein. In particular, isolated epitope peptides or immunogenic fragments derived from SEQ ID NO: 32, that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) are provided. The amino acid sequence of the peptide of interest may be optionally modified with the substitution, deletion, insertion, or addition of one, two, or several amino acids sequences. Pharmaceutical compositions and methods of treating cancer that include such peptides are also provided. | 11-21-2013 |
20130315942 | WDRPUH Epitope Peptides and Vaccines Containing the Same - The present invention provides peptides containing the amino acid sequence of SEQ ID NOs: 1, 2, 3, 4, 16, 17, 30, 31, 34, 36, 37, 40, 41, 45, 49, 55, 57 and 61, as well as peptides containing the above-mentioned amino acid sequences in which 1, 2, or several amino acid(s) are substituted, deleted, inserted or added, but still have cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing tumors, which drugs containing these peptides. The peptides of the present invention can also be used as vaccines. | 11-28-2013 |
20140023671 | TOMM34 PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 42, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for treating cancer. | 01-23-2014 |
20140141027 | PEPTIDE VACCINES FOR CANCERS EXPRESSING TUMOR-ASSOCIATED ANTIGENS - The present invention provides peptides having an amino acid sequence as set forth in SEQ ID NO: 19, 22, 30, 34, 344, 358, 41, 44, 46, 48, 78, 376, 379, 80, 100, 101, 110, 111, 387, 112, 394, 114, 116, 117, 121, 395, 133, 135, 137, 426, 143, 147, 148, 149, 150, 152, 153, 154, 156, 160, 161, 162, 163, 166, 174, 178, 186, 194, 196, 202, 210, 213, 214, 217, 223, 227, 228, 233, 254, 271, 272 or 288, as well as peptides having the above-mentioned amino acid sequences in which 1, 2, or several (e.g., up to 5) amino acids are substituted, deleted, or added, provided the peptides possess cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing a disease associated with over-expression of the CDH3, EPHA4, ECT2, HIG2, INHBB, KIF20A, KNTC2, TTK and/or URLC10, e.g. cancers containing as an active ingredient one or more of these peptides. The peptides of the present invention find further utility as vaccines. | 05-22-2014 |
20140154281 | MPHOSPH1 PEPTIDES AND VACCINES INCLUDING THE SAME - As discussed in greater detail herein, isolated epitope peptides derived from MPHOSPH1 bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines. The inventive peptides encompass both the above-mentioned MPHOSPH1-derived amino acid sequences and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted or added, provided such modified versions retain the requisite CTL inducibility of the original sequences. Further provided are polynucleotides encoding any of the aforementioned peptides as well as pharmaceutical agents or compositions that include any of the aforementioned peptides or polynucleotides. The peptides, polynucleotides, and pharmaceutical agents or compositions of this invention find particular utility in either or both of the treatment and prevention of cancers and tumors, including, for example, bladder cancer, breast cancer, cervical cancer, cholangiocellular carcinoma, CML, colorectal cancer, gastric cancer, NSCLC, lymphoma, osteosarcoma, prostate cancer, renal cancer and soft tissue tumor. | 06-05-2014 |
20140178409 | SEMA5B PEPTIDES AND VACCINES INCLUDING THE SAME - As discussed in detail herein, isolated epitope peptides derived from SEMA5B bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines. The inventive peptides encompass both the above mentioned amino acid sequences and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted or added, provided such modified versions retain the requisite HLA binding and/or CTL inducibility of the original sequences. Further provided are polynucleotides encoding any of the aforementioned peptides as well pharmaceutical agents or compositions that include any of the aforementioned peptides or polynucleotides. The peptides, polynucleotides, pharmaceutical agents or compositions of this invention find particular utility in the treatment and/or prevention of cancers and tumors, including, for example, esophageal cancer, NSCLC, RCC and SCLC. | 06-26-2014 |
20140199335 | C1ORF59 PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated peptides having the amino acid sequence of SEQ ID NO: 43 or immunologically active fragments thereof, which bind to HLA antigen and have cytotoxic T lymphocyte (CTL) inducibility. The present invention further provides peptides which include one, two, or several amino acid insertions, substitution or addition to the aforementioned peptides or fragments, but still have the cytotoxic T cell inducibility. Further provided are nucleic acids encoding any of these aforementioned peptides as well as pharmaceutical agents and compositions including any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical agents and compositions of this invention may be used for treating cancer or tumor. | 07-17-2014 |
20140199336 | TMEM22 PEPTIDES AND VACCINES INCLUDING THE SAME - Isolated peptides composed of the amino acid sequence of SEQ ID NO: 33 or fragments thereof that bind to HLA antigens and have cytotoxic T lymphocyte (CTL) inducibility and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines are described herein. The present invention further provides peptides that include one, two, or several amino acid insertions, substitutions or additions to the aforementioned peptides or fragments, but yet retain the requisite cytotoxic T cell inducibility. Further provided are nucleic acids encoding any of these aforementioned peptides as well as pharmaceutical agents, substances and compositions including any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical agents, substances and compositions of this invention find particular utility in the treatment of cancers and tumors. | 07-17-2014 |
20140255437 | TOPK PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated epitope peptides derived from TOPK and immunogenic fragments thereof have an ability to induce cytotoxic T lymphocytes (CTLs) and thus are suitable for use in cancer immunotherapy, more particularly as cancer vaccines. The peptides of the present invention encompass both of peptides including a TOPK-derived amino acid sequence and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted and/or added, provided such modified versions have CTL inducibility. Further provided are polynucleotides encoding any of the aforementioned peptides as well as pharmaceutical compositions that include any of the aforementioned peptides or polynucleotides. The peptides, polynucleotides, and pharmaceutical compositions of this invention find particular utility in either or both of the treatment and prevention of a number of cancers. | 09-11-2014 |
20140256648 | HJURP PEPTIDES AND VACCINES INCLUDING THE SAME - Isolated peptides derived from SEQ ID NO: 50 and fragments thereof that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable for use in cancer immunotherapy are described herein. The inventive peptides encompass both the above mentioned amino acid sequences and modified versions thereof, provided they retain the requisite cytotoxic T cell inducibility of the original sequence. Further provided are nucleic acids encoding the peptides as well as pharmaceutical agents, substances and/or compositions that include any of the peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical agents, substances and compositions of this invention find utility in the treatment of cancers, including, for example, AML, bladder cancer, breast cancer, cervical cancer, cholangiocellular carcinoma, CML, colorectal cancer, esophagus cancer, diffused-type gastric cancer, liver cancer, NSCLC, lymphoma, osteosarcoma, ovarian cancer, pancreatic cancer, prostate cancer, renal carcinoma, SCLC, soft tissue tumor and testicular tumor. | 09-11-2014 |
20150174223 | UBE2T PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. In particular, epitope peptides derived from the UBE2T that elicit CTLs are provided. Isolated antigen-presenting cells with CTL inducibility and CTLs that target such peptides, as well as methods for inducing the antigen-presenting cell, or CTL are also provided. The present invention further provides pharmaceutical compositions containing such epitope peptides derived from UBE2T or polynucleotides encoding the polypeptides as active ingredients. Furthermore, the present invention provides methods for the treatment and/or prophylaxis of (i.e., preventing) cancers (tumors), and/or the prevention of a postoperative recurrence thereof, as well as methods for inducing CTLs, methods for inducing anti-tumor immunity, using the epitope peptides derived from UBE2T, polynucleotides encoding the peptides, or antigen-presenting cells presenting the peptides, or the pharmaceutical compositions of the present invention. | 06-25-2015 |
20150290307 | NEIL3 PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 45, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include the above mentioned amino acid sequence with substitution deletion, or addition of one, two, or several amino acids sequences. The invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for diagnosing or treating cancer. | 10-15-2015 |
20150315239 | METHOD OF INDUCING AN IMMUNE RESPONSE BY ADMINISTERING WDRPUH EPITOPE PEPTIDES - The present invention provides peptides containing the amino acid sequence of SEQ ID NOs: 1, 2, 3, 4, 16, 17, 30, 31, 34, 36, 37, 40, 41, 45, 49, 55, 57 and 61, as well as peptides containing the above-mentioned amino acid sequences in which 1, 2, or several amino acid(s) are substituted, deleted, inserted or added, but still have cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing tumors, which drugs containing these peptides. The peptides of the present invention can also be used as vaccines. | 11-05-2015 |
20150322112 | SEMA5B PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. Isolated epitope peptides derived from the SEMA5B gene that elicit CTLs and thus are suitable for use in the context of cancer immunotherapy are provided. The peptides encompass both SEMA5B-derived peptides and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted or added, provided such modified versions retain the requisite CTL inducibility of the original sequences. Further provided are polynucleotides encoding such peptides as well as pharmaceutical compositions that include any such peptides or polynucleotides as active agents. Antigen-presenting cells and isolated CTLs that target such peptides, as well as methods for inducing the antigen-presenting cell, or CTL are also provided. Furthermore, the present invention provides methods for use in cancer immunotherapy. | 11-12-2015 |
20150374810 | TOMM34 PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 42, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for treating cancer. | 12-31-2015 |
Shin Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20140341483 | IMAGE PROCESSING APPARATUS AND IMAGE PROCESSING METHOD - There is provided an image processing apparatus including an image processing unit which performs image processing on each of a plurality of images of a same subject having different resolutions, and an image combining unit which combines an image processing result of each of the plurality of images obtained by the image processing unit. | 11-20-2014 |
20140347449 | IMAGING APPARATUS AND IMAGING METHOD - An imaging apparatus includes: a first imaging device configured to perform photoelectric conversion on subject light input through a first filter to output a first image signal, the first filter preventing light in a predetermined wavelength band of wavelengths longer than that of visible light from being transmitted; a second imaging device arranged at a different position from the first imaging device and configured to perform photoelectric conversion on subject light containing a wavelength component of the light in the predetermined wavelength band to output a second image signal; a correlation detection unit configured to detect a correlation between the first and second image signals; a luminance signal generation unit configured to generate a luminance signal; a color signal generation unit configured to generate a color signal; and a three-dimensional image generation unit configured to generate a three-dimensional image by the correlation, the luminance signal, and the color signal. | 11-27-2014 |
Shiyo Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20140245045 | CONTROL DEVICE AND COMPUTER PROGRAM PRODUCT - According to an embodiment, a control device includes a processor setting unit, a resumption data reading unit, and a resumption processing unit. The processor setting unit is configured to identify, among a plurality of processors included in an information processing system, each of which is connected to one or more memories, a processor connected to a memory storing resumption data for resuming the information processing system and to activate the identified processor, in response to a resumption request for resuming the information processing system from hibernation. The information processing system includes two or more processors each connected with one or more memories. The resumption data reading unit is configured to read the resumption data from the memory that stores the resumption data. The resumption processing unit is configured to resume the information processing system by using the read resumption data. | 08-28-2014 |
20140245047 | INFORMATION PROCESSING APPARATUS, OPERATION STATE CONTROL METHOD, AND COMPUTER PROGRAM PRODUCT - According to an embodiment, an information processing apparatus that includes a processor, has a first control unit, a power storage unit, and a second control unit. The first control unit is configured to control execution of a process by the processor. The power storage unit is configured to store therein power. The second control unit is configured to control reduction of power consumption of the information processing apparatus in a case where there is a process waiting to be executed and an amount of stored power of the power storage unit is equal to or less than a first threshold. | 08-28-2014 |
Shuichi Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20100286361 | PURIFICATION METHOD OF HIGH-MOLECULAR-WEIGHT POLYOXYALKYLENE DERIVATIVE - A purification method in which, from a specific polyoxyalkylene derivative having a molecular weight of 8,800 to 100,000, an impurity differing in the number of hydroxyl groups is separated, the method including steps (A), (B), (C), and (D). Step (A): a step in which an aprotic organic solvent is used in an amount at least 5 times by weight the amount of the polyoxyalkylene derivative to dissolve the polyoxyalkylene derivative therein and give a solution; step (B): a step in which an adsorbent comprising an oxide containing at least one of aluminum and silicon is added to the solution in an amount 0.5 to 5 times by weight the amount of the polyoxyalkylene derivative to thereby yield a slurry; step (C): a step in which the slurry is stirred at 25° C. or higher; step (D): a step in which the polyoxyalkylene derivative is recovered from the slurry. | 11-11-2010 |
20110218322 | POLYALKYLENE GLYCOL DERIVATIVE AND PROCESS FOR PRODUCING SAME - An object of the present invention is to provide a process for producing a polyalkylene glycol derivative having such high molecular weight and purity that the derivative can be used in pharmaceutical applications. | 09-08-2011 |
20120277477 | Method For Manufacturing Hydroxyl Group-containing Acetal Compound - A method for manufacturing an acetal compound represented by the formula [1] in which the steps (A) to (D) as defined herein are performed sequentially, and an acetal compound of the formula [1] which is produced by the method: | 11-01-2012 |
Takahiro Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20130204426 | Tool Path Generation Method and Apparatus - A method including a bend angle calculation step of calculating a bend angle θ at each connecting point of a broken line which is obtained by successively connecting a predetermined plurality of machining points P | 08-08-2013 |
20130211578 | Generation Method and Generation Apparatus of Tool Path - The objective of the present invention is to generate a new tool path quickly by means of a simple calculation formula without calculating an approximated curve and the like. A tool path is generated with procedures that include: a distance calculation procedure, whereby one of the processing points (Pi) on a multiple rows of tool paths (PA) obtained by connecting multiple prescribed processing points sequentially with straight lines is set as a revision processing point (Pt), points on the multiple rows of tool paths in the vicinity of this revision processing point (Pt) are set as distance calculation points (Pu), and the distance (L) from the revision processing point (Pt) to each of the distance calculation points (Pu) is calculated; an extraction procedure, whereby the distance calculation points (Pu′) for which the distance (L) calculated by the distance calculation procedure is within a prescribed value (ΔL) are extracted; a mean value calculation procedure, whereby the mean values of the position data for the distance calculation points (Pu′) extracted by the extraction procedure and the position data for the revision processing point (Pt) are calculated; and a data revision procedure, whereby the position data for the revision processing point (Pt) is revised by means of the mean values calculated by the mean value calculation procedures, and a new tool path (PA′) is created on the basis of the position data for the revised processing point (Pt′). | 08-15-2013 |
Tomohiro Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20130052684 | METHOD FOR PRODUCING USEFUL SUBSTANCES BY A RECOMBINANT ACTINOMYCETE, STREPTOMYCES SPECIES - The invention provides a promoter derived from a genome of an actinomycete, | 02-28-2013 |
Tomokazu Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20120320412 | IMAGE FORMING SYSTEM, IMAGE FORMING APPARATUS, AND COMPUTER READABLE MEDIUM - An image forming system includes a transmitter apparatus that transmits, to a predetermined storage location of multiple storage locations, identification information identifying a user and image data associated with the identification information, and multiple image forming apparatuses. Each of the image forming apparatuses includes a first storage unit that stores storage information indicating the storage locations, a storage location that is included in the storage locations and stores the identification information and the image data associated with the identification information, a retrieval unit that accesses the storage locations, indicated by the storage information stored on the first storage unit, when the identification information is inputted by the user, and retrieves the image data from the storage location, and an image forming unit that forms an image corresponding to the image data retrieved by the retrieval unit. | 12-20-2012 |
20130100488 | IMAGE FORMING SYSTEM, IMAGE FORMING APPARATUS, TRANSMISSION APPARATUS, AND NON-TRANSITORY COMPUTER READABLE MEDIUM - An image forming system includes at least one transmission apparatus, and plural image forming apparatuses, wherein the transmission apparatus includes a transmission section that transmits printing data to a first image forming apparatus of the plural image forming apparatuses, wherein the first image forming apparatus includes a receiving section that receives printing data from the transmission apparatus or other image forming apparatuses, and a printing data transmission section that transmits the printing data or substantially identical printing data generated on the basis of the printing data, to the image forming apparatuses other than the own apparatus among the plural image forming apparatuses, when printing data which is substantially identical to the printing data received by the receiving section cannot be acquired from the image forming apparatuses corresponding to the predefined reference number among the plural image forming apparatuses. | 04-25-2013 |
20140240758 | IMAGE FORMING APPARATUS, IMAGE FORMING METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM - An image forming apparatus includes a communication unit that communicates with multiple external image forming apparatuses each storing print data that is held until after printing is executed and identification information about a user, which is associated with the print data; a memory that stores print data and identification information about a user, which is associated with the print data; and a search unit that, upon specification of the identification information about the user, sequentially searches pieces of information stored in the memory and the multiple external image forming apparatuses for information corresponding to the specified identification information about the user and stops the search of the pieces of information stored in the memory and the multiple external image forming apparatuses, which are not searched, in response to a first search result that is achieved. | 08-28-2014 |
20140320924 | IMAGE FORMING SYSTEM, IMAGE FORMING APPARATUS, TRANSMISSION APPARATUS, AND NON-TRANSITORY COMPUTER READABLE MEDIUM - An image forming system includes at least one transmission apparatus, and plural image forming apparatuses, wherein the transmission apparatus includes a transmission section that transmits printing data to a first image forming apparatus of the plural image forming apparatuses, wherein the first image forming apparatus includes a receiving section that receives printing data from the transmission apparatus or other image forming apparatuses, and a printing data transmission section that transmits the printing data or substantially identical printing data generated on the basis of the printing data, to the image forming apparatuses other than the own apparatus among the plural image forming apparatuses, when printing data which is substantially identical to the printing data received by the receiving section cannot be acquired from the image forming apparatuses corresponding to the predefined reference number among the plural image forming apparatuses. | 10-30-2014 |
20140368864 | IMAGE FORMING SYSTEM, IMAGE FORMING APPARATUS, AND COMPUTER READABLE MEDIUM - An image forming system includes a transmitter apparatus that transmits, to a predetermined storage location of multiple storage locations, identification information identifying a user and image data associated with the identification information, and multiple image forming apparatuses. Each of the image forming apparatuses includes a first storage unit that stores storage information indicating the storage locations, a storage location that is included in the storage locations and stores the identification information and the image data associated with the identification information, a retrieval unit that accesses the storage locations, indicated by the storage information stored on the first storage unit, when the identification information is inputted by the user, and retrieves the image data from the storage location, and an image forming unit that forms an image corresponding to the image data retrieved by the retrieval unit. | 12-18-2014 |
Tomonari Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20090213464 | Light polarizing sheet and manufacturing method for same - Provides a light polarizing sheet which is easy to manufacture, offers the functionality of conventional multiple sheet structures, and satisfies both the luminance and viewing angle characteristics required for liquid crystal televisions and the like. | 08-27-2009 |
20150301262 | LIGHT GUIDE, MANUFACTURING METHOD OF LIGHT GUIDE, OPTICAL SHUTTER, AND PLANAR LIGHT-SOURCE DEVICE - Provided is a plate-type light guide ( | 10-22-2015 |
Toshihide Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20140067753 | INFORMATION PROCESSING APPARATUS, TRAIL COLLECTION SYSTEM, INFORMATION PROCESSING METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM - An information processing apparatus includes a sample extracting unit, a trail information memory, a trail acquisition instructing unit, a trail accepting unit, and a trail determining unit. The sample extracting unit extracts samples from a population. The trail information memory stores information about trails. The trail acquisition instructing unit provides an instruction to acquire a trail for a sample extracted by the sample extracting unit. The trail accepting unit accepts trails. The trail determining unit determines, every time the trail accepting unit accepts a trail, whether the accepted trail is valid or invalid in accordance with the information stored in the trail information memory. If the trail determining unit determines that the accepted trail is invalid, the trail acquisition instructing unit provides again an instruction to acquire a trail. | 03-06-2014 |
20160071073 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM - An information processing apparatus includes a memory that stores first data indicating an overview of billing or payment of money regarding a user, and second data indicating a specification of at least a part of the first data; a first generating unit that generates first image information which represents the first data before a request for the first image information being input; and a second generating unit that generates second image information which represents the second data in response to a request for the second image information being input. | 03-10-2016 |
Toshiya Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20130205270 | EDITING SYSTEM - An editing system includes a database server apparatus having product specification management data stored therein; and a terminal apparatus including: a display part displaying a function tree and an IO table, the function tree hierarchically indicating elements along with attributes of each of the elements based on the product specification management data and having a product name as a root of the function tree, and the IO table indicating connection data between each pin of the elements based on the product specification management data, an accepting part accepting an operation to connect one element to another element, an operation to display connection data between the elements, and an operation to edit each item of the connection data of the IO table, and an updating part updating the connection data of the product specification management data in accordance with the operations accepted by the operation accepting part. | 08-08-2013 |
Yasuaki Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20150133626 | METHOD OF PRODUCING POLYESTER RESIN HAVING CYCLIC ACETAL SKELETON - A method of producing a polyester resin comprising a dicarboxylate constitutional unit and a diol constitutional unit, the diol constitutional unit comprising a constitutional unit having a cyclic acetal skeleton, the method comprising reacting a diol (A) having a cyclic acetal skeleton, a bisalkyl dicarboxylate ester (B), and a diol (C) having no cyclic acetal skeleton in the presence of a basic compound (D). | 05-14-2015 |
Yasuo Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20160058411 | ULTRASONIC URINE VOLUME MEASURING INSTRUMENT, URINE VOLUME MANAGEMENT DATA GENERATING METHOD USING ULTRASONIC URINE VOLUME MEASURING INSTRUMENT, AND BLADDER TRAINING METHOD USING ULTRASONIC URINE VOLUME MEASURING INSTRUMENT - An ultrasonic urine volume measuring instrument includes an ultrasound probe, an ultrasound controller that controls transmission and reception of ultrasound and its reflected waves, and an arithmetic unit that calculates urine volume in the bladder on the basis of the reflected waves. The arithmetic unit includes a comparator that compares the calculated urine volume in the bladder with a first threshold. The ultrasound measurement cycle becomes a longer cycle when the urine volume in the bladder is less than the first threshold, compared to the urine volume being greater than or equal to the first threshold. The ultrasonic urine volume measuring instrument includes a timer unit capable of causing, when the urine volume in the bladder compared by the comparator is less than the first threshold, the arithmetic unit to enter a sleep state during each measurement cycle, and causes the arithmetic unit to recover every measurement cycle. | 03-03-2016 |
20160058412 | ULTRASONIC URINE VOLUME MEASURING INSTRUMENT, AND METHOD OF POSITIONING ULTRASOUND PROBE IN ULTRASONIC URINE VOLUME MEASURING INSTRUMENT - A mode selector is provided, capable of selecting one of a measurement mode of measuring urine volume while an ultrasound probe is placed at a certain measurement position on the stomach of a measurement subject, and a positioning mode is provided, of measuring urine volume while moving the ultrasound probe to a plurality of tentative measurement positions on the stomach to determine the measurement position suitable for placing the ultrasound probe in the measurement mode. An index value memory is included that stores a maximum value among urine volumes at the plurality of tentative measurement positions, calculated by the arithmetic unit, while the positioning mode is being selected, and/or an allowance value determined on the basis of the maximum value. The maximum value and/or the allowance value is displayed, on a graph on a display unit, as a positioning index value for positioning the ultrasound probe. | 03-03-2016 |
Yoshihiro Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20100051185 | Image formation apparatus and method for forming image - An image formation apparatus includes a transporting section configured to transport a thermal transfer sheet; a carrying section configured to carry a thermal transfer receiving sheet; a thermal head configured to sequentially thermally transfer the color material layer and the protective layer of the thermal transfer sheet onto the thermal transfer receiving sheet by applying thermal energy; and a controlling section configured to control the thermal energy, wherein the controlling section is configured to print an image under printing conditions where variation ΔH in a thickness of the thermal transfer receiving sheet in an increase direction before and after the thermal transfer of the color material layer satisfies 0<ΔH, and variation ΔL in the thickness of the thermal transfer receiving sheet in the increase direction before and after the thermal transfer of the protective layer satisfies ΔL<0. | 03-04-2010 |
20100321460 | PRINTING APPARATUS AND THERMAL TRANSFER PRINTING METHOD - Provided is a printing apparatus including: a medium transporting unit configured to transport a printing target medium; a sheet traveling unit configured to allow a thermal transfer sheet, in which a color material layer and a protection layer are formed on a sheet in a line along a travel direction, to travel; a printing unit configured to sequentially and thermally transfer the color material layer and the protection layer onto the printing target medium by applying thermal energy to the printing target medium and the thermal transfer sheet which are sandwiched by the printing unit; and a pressure changing mechanism configured to change the sandwiching force acting on the printing target medium and the thermal transfer sheet so as to have a relationship of force P | 12-23-2010 |
Yuichi Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20130036320 | IMAGE FORMING APPARATUS, FEEDING CONTROL METHOD, AND COMPUTER PROGRAM PRODUCT - An image forming apparatus includes a main power supply configured to feed power to components of the image forming apparatus; a secondary battery configured to be charged with power from the main power supply or a solar battery; a secondary battery deterioration detector configured to monitors a charging voltage drop of the secondary battery and to detect deterioration of the secondary battery; a secondary battery charge unit configured to charge the secondary battery when the secondary battery deterioration detector detects deterioration of the secondary battery in an energy-saving mode; and an energy-saving mode control unit configured to switch a power source for the image forming apparatus from the secondary battery to the main power supply to continue in the energy-saving mode when the secondary battery deterioration detector detects deterioration of the secondary battery in the energy-saving mode. | 02-07-2013 |
Yusuke Yoshimura, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20090278135 | THIN FILM TRANSISTOR, METHOD OF MANUFACTURING THE SAME, AND DISPLAY DEVICE USING THE SAME - Disclosed herein is a thin film transistor, including: a gate electrode; a crystallized semiconductor layer formed through a gate insulating film on the gate electrode; and a drain electrode and a source electrode provided on both end sides of the crystallized semiconductor layer, respectively, and provided through impurity doped layers each contacting the crystallized semiconductor layer, respectively. | 11-12-2009 |